Neurocrine Biosciences
NBIX
NBIX
218 hedge funds and large institutions have $4.7B invested in Neurocrine Biosciences in 2015 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 92 increasing their positions, 72 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
218
Holders Change
+11
Holders Change %
+5.31%
% of All Funds
5.72%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
35
Increased
92
Reduced
72
Closed
23
Calls
$36.2M
Puts
$28.1M
Net Calls
+$8.07M
Net Calls Change
-$28.1M
Top Buyers
Top Sellers
| 1 |
O
OrbiMed
New York
|
$142M |
| 2 |
PA
Perceptive Advisors
New York
|
$141M |
| 3 |
Jennison Associates
New York
|
$28M |
| 4 |
TCP
Tourbillon Capital Partners
New York
|
$0 |
| 5 |
Millennium Management
New York
|
$59.8M |
